MarketInOut Stock Screener Log In | Sign Up

Lunit Inc

KRX • Healthcare • Health Information Services • Quote as of 10/28/2026 14:30
Lunit Inc stock price and volume chart

Company Profile

IndustryHealth Information Services
SectorHealthcare
ExchangeKRX
Market Capitalization818,295 mln
Float62.75 mln

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-1.27
Manipulation likely

Relative Strength

99 / 100
Top performer

Debt / Equity

0.33
Low leverage

Pre-Tax Margin

-59%
Severely loss-making

ROE

-30.93
Deeply negative

Business Description

Founded in Seoul in 2013, Lunit is a South Korean company that uses artificial intelligence to help doctors detect and treat cancer more effectively. Its tools support the analysis of medical scans such as chest X-rays and mammograms, while also helping researchers identify biological markers that can guide treatment decisions. The company works alongside major pharmaceutical and life sciences firms, including AstraZeneca, Agilent Technologies, and Daiichi Sankyo, to advance cancer research and drug development.

Key Fundamentals

EPS-1,467
ROE-30.93
RPS1,461
ROIC-13.06
ROA-13.21
EBITDA, mln-13,561
EV / EBITDA-52.72
EV / EBIT-29.44
Revenue, mln91,818
EV / Revenue7.79

Quote Details

Last 14,310
Change -340 (-2.32%)
Open 14,730
Volume 1,728,639
Turnover 24,736,823,296
Average Volume 1,514,595

Financial Ratios

Pre-Tax Profit Margin-59
Current Ratio1.10
Price / Book2.44
Price / Tangible Book21.28
Debt / Equity0.33
Price / Sales7.70

Financial Strength

Altman Z-Score1.14
Piotroski F-Score 6 / 9
Beneish M-Score-1.27

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 24.33% 99 / 100   
1 Month 45.87% 99 / 100   
2 Months 42.53% 96 / 100   
6 Months -21.8% 52 / 100   
1 Year -31.28% 28 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog